P1.04-32 Phase I/II Study of the A2AR Antagonist NIR178...

Journal of Thoracic Oncology 2018 / 10 Vol. 13; Iss. 10

P1.04-32 Phase I/II Study of the A2AR Antagonist NIR178 (PBF-509), an Oral Immunotherapy, in Patients (pts) with Advanced NSCLC

Chiappori, A., Williams, C., Creelan, B., Tanvetyanon, T., Gray, J., Haura, E., Chen, D.T., Thapa, R., Beg, A., Boyle, T., Sangani, M., Morris, E., Tao, A., Hurtado, F., Manenti, L., Castro, J., Anton
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2018.08.747
Date:
October, 2018
File:
PDF, 178 KB
english, 2018
Conversion to is in progress
Conversion to is failed